Background: Merkel cell carcinoma (MCC) is a rare neuroendocrine skin tumor, which may be related to sun exposure. It can metastasize to lungs, liver and bone, leading to severe morbidity and mortality. Vertebral metastases from MCC are rare. The authors report the tenth case in the literature, a 59-year-old patient with MCC, which was primarily localized in the scalp, and later provoked distant metastasis to the thoracic spinal column. Case Description: A 59-year-old woman was admitted at our Unit of Neurosurgery with a 4-month history of progressive and severe dorsal back pain, without neurological signs. The patient had been surgically treated for a recidivated MCC in the occipital region in 2007 , 2011, the surgical treatment also included lateral cervical lymph node dissection). Chemotherapy and radiotherapy had come after the treatments. Magnetic resonance imaging (MRI) of the dorsal spine showed metastatic vertebral involvement with cord impingement of the T7-T8 levels. A total body CT scan revealed lungs and liver metastases, besides vertebral district. After a multidisciplinary consult a palliative surgery was decided and a posterior dorsal approach was employed: Radiofrequency (RF) thermoablation was followed by the injection of cement of T7 and T8 and transpedicle fixation T5-T9. The postoperative course was uneventful and followed by a further adjuvant therapy Conclusion: Spinal metastases from MCC are described in literature only exceptionally. The clinical course is presented, along with a review of literature.
INTRODUCTION
Merkel cell carcinoma (MCC) is a rare malignant and aggressive neuroendocrine cutaneous tumor, with a poor prognosis, firstly described by Friedrich Sigmund Merkel in 1875. [14] Approximately 0.3-0.6/100.000 MCCs are diagnosed annually in the United States, moreover, the incidence has been increasing in the last few decades. [1] The mean age at diagnosis of MCCs is 75 years. [16] It typically occurs as a painful reddish lesion, more commonly in sun exposed areas, head, neck, and arms. [10] It is often mistaken for a basal or a squamous skin cancer. [19] Risk factors, besides sun exposure, are: Immunosuppression (MCC is also described transplant patients) and male sex. [19, 20] An effective role of human leukocyte antigen (HLA) system in the pathogenesis has not been still clarified as in other malignancies. [11] These tumors tend to local invasiveness, recurrence, and sometimes to distant metastasization. For patients who have distant metastases, the prognosis is even lower. [19] The osseous involvement of the spine is rare: To our knowledge, there are only nine cases reported. [16] In consideration of the very low number of reports, there is no standardized guidelines for this lesions management. We report the tenth case in literature, a 59-year-old patient with a head MCC metastasized to the thoracic spinal column.
CASE DESCRIPTION
A 59-year-old female was admitted at our Unit of Neurosurgery with a 4-month history of progressive and severe dorsal back pain without neurological signs. The patient had been previously surgically treated in 2007, 2011, and 2013 for a recidivated MCC in the occipital region, firstly mistaken for a basal cell carcinoma. The resection had been followed by several cycles of chemotherapy (5-fluorouracil and cisplatin) and local radiotherapy. In the last surgical excision, a lateral cervical lymph node dissection had been performed. The patient had no other comorbidities or any other cancer and she was not immunocompromised. Two years later, the patient complained the onset of progressive pain in the dorsal region. After the admission at our Unit, a Magnetic Resonance Imaging (MRI) with gadolinium contrast medium of the dorsal spine was performed. A neoplastic involvement of two vertebral bodies (T7 and T8) was visible on the contrast-enhanced T1-weighted images [ Figure 1a ], a local cord impingement and a segmental local kyphosis were visible on T2-weighted images [ Figure 1b ], while and an osteolytic shape was visible on Short-T1 Inversion Recovery (STIR) sequence [ Figure 1c ]. A total body computed tomography (CT) showed several lungs and liver metastases. Neurologic examination was unremarkable. A multidisciplinary consultation was performed, a palliative surgery was decided and the patient was operated employing a posterior dorsal approach based on the use of radiofrequency (RF) thermoablation (MetaSTAR, Dfine, San Jose, USA), followed by the injection of polymethyl methacrylate (PMMA) in T7 and T8 vertebral body and a transpedicle fixation T5-T9. [13] The histopathological analysis of the vertebral body biopsy confirmed that the metastasis is derived from the MCC. Postoperative MRI showed a reduction of the neoplastic volume in both involved vertebral bodies (T7 and T8) [ Figure 2a and b], while a thoracic CT scan revealed the improvement of the segmental thoracic curvature with correct pedicle fixation and a partial vertebral augmentation [ Figure 2c and d]. The postoperative course was uneventful and there was a significant reduction of dorsal pain. The patient is still alive after 8 months, in good general conditions and is going through chemo and radiotherapy.
DISCUSSION
The spine is the most common site for bone metastases; otherwise it accounts for a very low rate of central nervous system dissemination of local primary tumors. [4] Nowadays, the incidence of spinal secondary involvement is increasing, especially among elderly people, because of longer life expectancy and medical treatments improvement. Seventy percent of cancer patients do have spinal metastases; furthermore, up to 10% of cancer patients develop metastatic cord compression. The tumors that most frequently spread to the spine are: Breast, lung, renal, prostate, thyroid, melanoma, myeloma, lymphoma, and colorectal cancer. [3, 8, 23] MCC is a rare malignant neuroendocrine primary skin cancer that arises from epithelial cells known as "touch cells" or "Merkel cells." These cells are involved in mechanic perception, together with sensory neurons located in the dermal-epidermal junction. [25] This tumor shows a remarkable tendency to local invasiveness, while distant metastasization is not frequent. In any case, spinal cord metastasis from MCC is very rarely described. To the best of our knowledge, we are reporting the tenth case in the literature [ Table 1 ]. [2, 5, 12, 15, 16, 17, 18, 21, 22] Among these nine cases reported, only six had been treated surgically. Despite the introduction of minimally invasive spine endoscopic surgery, no one of the cases reported underwent endoscopic transthoracic removal. [24] Our case is the first one in which a segmental dorsal kyphosis was treated with posterior fixation and a RF coblation of vertebral metastatic lesions. Four out of six patients died short after the treatment, because of the multisystemic failure caused by the illness systemic dissemination. Among those six patients whose treatment was surgery, only four were operated by decompression, [12, 17, 21, 22] while two of them underwent decompression and had an implant of stabilization with screws and rods. [5, 16] Among the patients surgically treated with posterior decompression only, the first one presented a L5 metastasis from a primary epigastric MCC, [21] the second one presented a metastatic localization at the eighth dorsal vertebra, [22] while the other two patients had metastases localized respectively at C6 and T6-T8. [12, 17] Decompression together with stabilization were performed only in one patient, who showed a large paraspinal localization from T5 to T7, with a massive T6 vertebral body involvement. [16] The second patient presented a metastatic localization at T5, the treatment was: Corpectomy, cage placement, and posterior fixation. [5] All the patients who underwent surgery have died within few months after the operation. In our case, the cutaneous carcinoma in the occipital region was firstly removed in 2007, then in 2011 and 2013. In this last occasion, the removal was followed by lateral cervical lymph node dissection. The patient had no other comorbidities, no other tumor, and she was not immunocompromised. After 2 years, she complained the onset of progressive pain in the dorsal region. An MRI showed a neoplastic involvement of the T7 andT8 vertebral bodies. When evaluating a patient with MCC, there are many risk factors to be considered. These factors can increase the likelihood of recurrence or metastases. [19, 20] The acronym Asymptomatic, Expanding rapidly, Immune suppression, Older than 50-year old, Ultraviolet (AEIOU) well sums up this tumor's main features: Asymptomatic, expanding rapidly, immune suppression, older than 50-years-old, and ultraviolet (UV) exposure on fair skin. [9] In our case, the patient had no previous history of excessive sun exposure, nor was she immunosuppressed.
The mortality rate for patients diagnosed with a primary skin MCC metastases is very high. MCC management, although not standardized, consists of a wide resection with 1-2 cm margin, followed by adjuvant therapy. It has been proved that postsurgical radiotherapy does ameliorate the prognosis and reduce local cancer recurrence at 3 years. On the contrary, chemotherapy seems not to interfere with the overall survival. [7] The majority of patients diagnosed with skin cancer metastases often receive palliative treatments. Due to poor prognosis at this stage of disease, surgical treatment is considered only in case of mechanical instability, intractable pain, or progressive neurological dysfunction. [6, 12, 16, 17, 21, 22, 26] Indeed, our patient presented segmental thoracic kyphosis and increasing back pain. After a multidisciplinary consultation, we decided to treat her with a posterior dorsal approach by performing RF thermoablation followed by the injection of PMMA of T7 and T8 and a transpedicle fixation T5-T9.
Percutaneous imaging-guided ablative therapies using thermal energy sources such as RF, microwave, laser, and high-intensity focused sonography have received much recent attention as minimally invasive strategies for the treatment of focal malignant diseases. The main aim of thermal tumor ablation therapy is to destroy a variable quote of tumor by using heat to kill the malignant cells in a minimally invasive fashion without damaging adjacent vital structures. Possible advantages include low cost, suitability for real-time imaging guidance, and the ability to perform ablative procedures on outpatients. Radiofrequency thermal ablation (RFTA) is considered the treatment of choice for osteoid osteomas, in which it has long been safely used. Other benign conditions (chondroblastoma, osteoblastoma, giant cell tumor, etc.) can also be treated by this technique, which is less invasive than traditional surgical procedures. RFTA ablation is also an option for the palliation of localized, painful osteolytic metastatic, and myeloma lesions. The reduction in pain improves the quality of life of patients with cancer, who often have multiple morbidities and a limited life expectancy. In some cases, these patients are treated with RFTA because conventional therapies (surgery, radiotherapy, chemotherapy, etc.) have been exhausted. In other cases, it is combined with conventional therapies or other percutaneous treatments, e.g., cementoplasty, offering faster pain relief and bone strengthening. [13] In this case, the postoperative course was uneventful and followed by a further adjuvant therapy. The patient is still alive and in good general conditions after 8 months. This case report suggests that in the advanced stage of MCC, spinal cord metastases surgical treatment must be considered if the patient complains back pain, even in absence of neural signs or symptoms.
CONCLUSION
MCC is an uncommon nonmelanoma skin cancer. There is a high-risk subgroup that develops distant metastases to lungs, mediastinum, liver, or bone, which are associated to a bad prognosis. Spinal localization is very rarely reported in literature. However, this hypothesis must be considered in presence of a patient having a history of MCC and complaining back pain, even in absence of neural signs or symptoms. Our case demonstrates that a selected surgery of vertebral metastases may permit improved survival and better life quality. Larger multicenter studies are needed, in order to determine the real risk of metastases and death connected to this cancer, as well as to confirm the role of surgical and adjuvant therapies in this specific subgroup of patients with MCC, to further guide management.
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